Literature DB >> 9536324

Calcitonin in the treatment of osteoporosis.

C Gennari1, A Camporeale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9536324     DOI： 10.1007/bf03194364

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  33 in total

1.  Nasal calcitonin for treatment of established osteoporosis.

Authors:  K Overgaard; B J Riis; C Christiansen; J Pødenphant; J S Johansen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-04       Impact factor: 3.478

2.  Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection.

Authors:  J Y Reginster; P Franchimont
Journal:  Clin Exp Rheumatol       Date:  1985 Apr-Jun       Impact factor: 4.473

3.  [Treatment of primary osteoporosis with calcium and salmon calcitonin].

Authors:  J D Ringe
Journal:  Dtsch Med Wochenschr       Date:  1990-08-03       Impact factor: 0.628

4.  Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors:  G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

5.  The effect of rectal and nasal administration of salmon calcitonin in normal subjects.

Authors:  T Buclin; J P Randin; A F Jacquet; M Azria; M Attinger; F Gomez; P Burckhardt
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

6.  Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.

Authors:  C Gennari; D Agnusdei; A Camporeale
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.

Authors:  M C Ellerington; T C Hillard; S I Whitcroft; M S Marsh; B Lees; L M Banks; M I Whitehead; J C Stevenson
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

8.  Formation of neutralizing antibodies after treatment with human calcitonin.

Authors:  A Grauer; H H Reinel; S Lunghall; E Lindh; R Ziegler; F Raue
Journal:  Am J Med       Date:  1993-10       Impact factor: 4.965

9.  Pharmacological control of osteoclastic motility.

Authors:  T J Chambers; C J Dunn
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

10.  Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.

Authors:  G P Lyritis; N Tsakalakos; B Magiasis; T Karachalios; A Yiatzides; M Tsekoura
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333
View more
  2 in total

1.  Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Controlled Delivery of Salmon Calcitonin Using Thermosensitive Triblock Copolymer Depot for Treatment of Osteoporosis.

Authors:  Lindsey Lipp; Divya Sharma; Amrita Banerjee; Jagdish Singh
Journal:  ACS Omega       Date:  2019-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.